Lipid Nanoparticles (SLN®, NLC®) for Cutaneous Drug Delivery:Structure, Protection and Skin Effects
Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) are new drug delivery systems composed of physiological lipid materials and surfactants accepted by regulatory authorities for application in cutaneous drug delivery, i.e., topical, dermal and transdermal. They have a whole set of unique advantages which make them very reliable in the development of topical and dermatological formulations. This review article focuses on the definitions and properties of these colloidal carriers including the production techniques and suitable formulations. Pharmaceutical considerations are also addressed on the basis of physicochemical stability of such carriers as well as of drug retention onto the lipid matrix. The drug diffusion enhancing effect of SLN and NLC into the skin is also discussed. Advantages of these carriers on minimizing/avoiding skin side effects are also emphasized.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
Document Type: Review Article
Publication date: 2007-12-01
More about this publication?
- Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- Terms & Conditions
- Ingenta Connect is not responsible for the content or availability of external websites